Published in Hepatitis Weekly, May 5th, 2003
The vaccine, developed by researchers at the Karolinska Institute at Huddinge University Hospital in Stockholm, Sweden, contains the genetic components of HCV nonstructural proteins. The gene gun method of delivery appears particularly suited for its administration, researchers report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.